• Home
• »Pharmacy Services
• » Pharmacy and Therapeutic Committee Reports

Contact Us |

Pharmacy and Therapeutic Committee

Reports | Presentations

Reports

• RD214 - Virginia’s Preferred Drug List: Program Implementation Outcomes and Recipient Health Effects

• HD60 - Inclusion of Antidepressants and Anti-Anxiety Drugs in the Virginia Medicaid Preferred Drug List (PDL) Program

• November 8, 2004 Status Report on the Medicaid Preferred Drug List Program and Other Pharmacy Initiatives

• October 7, 2004 Status Report on PDL Review of Antidepressants and Antianxiety Medications

• February 12, 2004: Status Report of Implementation of a PDL to the General Assembly

• December 16, 2003, Virginia Medicaid Preferred Drug List and Other Pharmacy Programs: What You Need to Know

• October 7, 2003 Status Report On Virginia’s Medicaid

• September 1, 2003:  Status Report of Implementation of a PDL to the General Assembly

• July 11, 2003:  Status Report on Development of PDL Program, Cynthia B. Jones to House Subcommittee

• June 18, 2003:  Status Report on the Development of a Medicaid Preferred Drug List Program (PPT), Cynthia B. Jones 

• June 16, 2003:  Status Report on the Implementation of a Medicaid Preferred Drug List Program to the General Assembly

• May 6, 2003:  Status Report on Development of Medicaid PDL,  presentation to JCHC (PPT)

• April 1, 2003:  Report to the General Assembly

Presentations

• January 26, 2004 Presentation to Presentation to Senate Finance Committee, Health & Human Resources Subcommittee

• August 4, 2004 PDL Presentation to the Joint Commission on Health Care Behavioral Health Subcommittee (PPT)

• July 8, 2003: Dr. Randy Axlrod's presentation to the Behavioral Health Commission

• June 18, 2003:  Roles of DMAS, Pharmacy & Therapeutics Committee, and Preferred Drug List Contractor (PPT), Patrick W. Finnerty

• Preferred Drug List (PDL) Program to the Joint Commission on Health Care Behavioral Health Subcommittee